08/28/2026
There is a very exciting phase 3 clinical trial occurring at Center for Vulvovaginal Disorders Florida in Tampa, Florida studying a new non-steroid topical cream for ge***al lichen sclerosus (JAK-inhibitor). If you have symptomatic itch due to ge***al lichen sclerosus and are within driving distance of Tampa (ideally within 2-3 hours; able to commit to 17 study visits over one year- more frequent for first month, then about once a month) please contact Clinical Research Coordinator Gracie at [email protected] for more information and telephone prescreening to see if you qualify. Must have diagnosis of only lichen sclerosus and no ge***al lichen planus for this study. Vulvar biopsy showing lichen sclerosus strongly preferred (please have available), but not mandatory. Must stop topical steroid (or other LS treatments) prior to starting the study, but may continue vaginal estrogen and other hormone therapy. Every participant has exams with Dr Jill Krapf. There is compensation for each visit paid at week 10 and at the end of the study. Screening does not guarantee eligibility. Participation is voluntary. If interested, contact Gracie at [email protected].